Stabilized formulations of CNS compounds

Details for Australian Patent Application No. 2011235222 (hide)

Owner Supernus Pharmaceuticals Inc.

Inventors Chang, Rong-Kun; Vieira, Michael L.; Liang, Likan; Bhatt, Padmanabh P.; Huang, Austin B.; Patel, Sachin V.

Agent Spruson & Ferguson

Pub. Number AU-A-2011235222

PCT Pub. Number WO2011/123497

Priority 61/282,787 31.03.10 US

Filing date 30 March 2011

Wipo publication date 6 October 2011

International Classifications

A61K 9/22 Medicinal preparations characterised by special physical form - Sustained or differential release type

A61K 9/52 Medicinal preparations characterised by special physical form - Sustained or differential release type

Event Publications

4 October 2012 PCT application entered the National Phase

  PCT publication WO2011/123497 Priority application(s): WO2011/123497

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011235227-Derivatives of 1-amino-2-cyclopropylethylboronic acid

2011235221-Formulations of mazindol